TransCode Therapeutics In... (RNAZ)
NASDAQ: RNAZ
· Real-Time Price · USD
10.75
-0.30 (-2.71%)
At close: Aug 15, 2025, 1:09 PM
TransCode Therapeutics Stock Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for RNAZ stock have an median target of 280, with a low estimate of 280 and a high estimate of 280. The median target predicts an increase of 2504.65% from the current stock price of 10.75.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 280 | 280 | 280 | 280 |
| Change | 2504.65% | 2504.65% | 2504.65% | 2504.65% |
Latest Analyst Insight Report
HC Wainwright & Co. has reaffirmed a Buy rating fo... Unlock content with Pro Subscription
Updated Apr 16, 2025
| Rating | Oct 24 | Nov 24 | Dec 24 | Feb 25 | Mar 25 | Apr 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 0 | 0 | 0 |
| Buy | 1 | 1 | 0 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 1 | 1 |
Financial Forecast this Year
Revenue This Year
1M
from 0
Increased by n/a%
Revenue Next Year
500K
from 1M
Increased by -50%
EPS This Year
-45.64
from -47.14
Increased by 3.2%
EPS Next Year
-8.96
from -45.64
Increased by 80.4%